NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Hydrochlorothiazide


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Akorn Reports Third Quarter 2009 Financial Results; Launches Two New Products: Ketorolac Tromethamine Ophthalmic and Hydralazine HCL
2009 NOV 23 ... Cyclooxygenase Inhibitor, Diphtheria, Drugs, Flu Vaccines, Hydralazine Hydrochloride, Hydrochlorothiazide, Immunization, Infectious Disease, Influenza Vaccines, Ketorolac, Marketing and ...
Subject: Akorn, Inc.
Price: $3.00
*
Data on pharmacokinetics detailed by researchers at Virginia Commonwealth University
2009 OCT 19 ... that has proven most difficult," scientists in the United States report. "Hydrochlorothiazide is a commonly used thiazide diuretic; whereas chlorthalidone is a structurally similar ...
Subject: Pharmacokinetics
Price: $3.00
*
FibroGen Announces New Research in Anti-CTGF and HIF-PHI Therapeutic Development Programs in Kidney Disease
2009 NOV 16 ... to reach a plateau after 8-10 weeks of dosing. Sodium restriction, losartan, and hydrochlorothiazide reduce elevated urinary CTGF/CCN-2 levels in patients with non-diabetic proteinuria ...
Subject: FibroGen, Inc.
Price: $3.00
*
Findings from Hamamatsu University, Medical Department in angiotensins reported
2009 NOV 9 ... Cardiovascular Disease, Drugs, Fibrosis, Hepatology, Hydralazine Hydrochloride, Hydrochlorothiazide, Malnutrition, Pharmaceuticals, Therapy, Treatment, Hamamatsu University, Medical ...
Subject: Angiotensins
Price: $3.00
*
Findings from R. Brody and co-authors broaden understanding of life sciences
2009 NOV 23 ... "3T3-L1 adipocytes were incubated for 6 h with increased doses of the following drugs: hydrochlorothiazide, atenolol, losartan, telmisartan, captopril, and nifedipine. Adiponectin levels, as well ...
Subject: Life Sciences
Price: $3.00
*
Findings from Z. Vujic and co-authors broaden understanding of chromatography
2009 NOV 24 ... chromatographic method with UV detection has been developed for the determination of hydrochlorothiazide (HCTZ), cilazapril (CL) and its active metabolite cilazaprilat (CLT) in urine. Sample ...
Subject: Chromatography
Price: $3.00
*
Findings in kidney disease reported from Nihon University, Medical Department
2009 OCT 12 ... the renoprotective and blood pressure-lowering effects of combination losartan-low-dose hydrochlorothiazide with losartan alone in hypertensive patients with stage 3 chronic kidney disease (CKD). ...
Subject: Kidney Disease
Price: $3.00
*
Four Pharmaceutical Companies Pay $124 Million for Submission of False Claims to Medicaid
2009 NOV 2 ... acetate, selegiline HCL, Orphenadrine Citrate Aspirin and Caffeine tablets, Triamterene/Hydrochlorothiazide, Propoxyphene HCL, Propoxyphene HCL/Aspirin/Caffeine, Prophyxphene ...
Subject: Medicare and Medicaid
Price: $3.00
*
New angiotensins research from Nihon University outlined
2009 NOV 23 ... II Type I receptor blocker 50 mg of losartan and a fixed combination of losartan (50 mg)/hydrochlorothiazide (12.5 mg) was administered to hypertensive patients with Stage 3 - 4 chronic kidney ...
Subject: Angiotensins
Price: $3.00
*
New angiotensins study results from Y. Matsui et al described
2009 NOV 9 ... monotherapy for 12 weeks, followed by additional use of azelnidipine (n = 103) or hydrochlorothiazide (n = 104) for 24 weeks after randomization. The central BP by radial artery tonometry, ...
Subject: Angiotensins
Price: $3.00
*
New findings from N. Gowda and co-researchers in the area of analytical science described
2009 NOV 26 ... least squares calibrations were developed for determination of nebivolol (NEB) and hydrochlorothiazide (HCTZ) in formulations without prior separation or masking. The HPLC assay utilized a ...
Subject: Analytical Science
Price: $3.00
*
New hypertension study findings have been published by A. Pareek and colleagues
2009 NOV 2 ... was to evaluate the efficacy of metoprolol XL/chlorthalidone against metoprolol XL/hydrochlorothiazide with respect to mean fall in systolic and diastolic blood pressure." "The ...
Subject: Hypertension
Price: $3.00
*
Recent findings from F. Luo and co-authors highlight research in hypotension
2009 NOV 9 ... is a risk factor for hypertension, has an impact on the antihypertensive response to hydrochlorothiazide, and is associated with orthostatic hypotension, we performed a case-control study of ...
Subject: Hypotension
Price: $3.00
*
Reports from Cornell University describe recent advances in life sciences
2009 NOV 2 ... domain complexed with benzothiadiazide derivatives (IDRA-21, hydroflumethiazide, hydrochlorothiazide, chlorothiazide, trichlormethiazide, and althiazide) for comparison with an existing ...
Subject: Life Sciences
Price: $3.00
*
Research data from Kumamoto University update understanding of enzyme research
2009 OCT 5 ... Femoral Artery, Fibrosis, Glomerulosclerosis, Hepatology, Hydralazine Hydrochloride, Hydrochlorothiazide, Hypertension, Hypertrophy, Inflammation, Kidney, Nephrology, Nitric Oxide, ...
Subject: Enzyme Research
Price: $3.00
*
Research from S.G. Chrysant and co-researchers yields new findings on hypertension
2009 NOV 1 ... (AML) plus olmesartan medoxomil (OM) 5+40 mg/d, up-titrated to AML+OM 10+40 mg/d plus hydrochlorothiazide (HCTZ) 12.5 mg then 25 mg if patients did not achieve blood pressure (BP) goal (< ...
Subject: Hypertension
Price: $3.00
*
Studies from N. Reichek et al provide new data on angiotensins
2009 NOV 9 ... of amlodipine/benazepril at doses 5.0/20.0 mg, 5.0/40.0 mg, and 10.0/40.0 mg with hydrochlorothiazide/benazepril at doses 12.5/20.0 mg, 12.5/40.0 mg, and 25.0/40.0 mg on the reduction of ...
Subject: Angiotensins
Price: $3.00
*
Studies from University of Sao Paulo have provided new information about angiotensins
2009 NOV 23 ... (ISI), and secretion (HOMA-beta) was performed, both before and 12 weeks after hydrochlorothiazide (HCT; 25 mg/d) therapy. At baseline, higher HOMA IR and HOMA-beta and lower ISI and ...
Subject: Angiotensins
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login